Cite
Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice
MLA
Zanichelli, A., et al. “Long-Term Safety of Icatibant Treatment of Patients with Angioedema in Real-World Clinical Practice.” Allergy, vol. 72, Mar. 2017, pp. 994–98. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb01c266c11afac0e4a5e05fdf4a6c39&authtype=sso&custid=ns315887.
APA
Zanichelli, A., Maurer, M., Aberer, W., Caballero, T., Longhurst, H. J., Bouillet, L., Fabien, V., Andresen, I., Grumach, A., Bygum, A., Blanchard Delaunay, C., Boccon-Gibod, I., Coppere, B., Du Thanh, A., Dzviga, C., Fain, O., Goichot, B., Gompel, A., Guez, S., … Garcez, T. (2017). Long-term safety of icatibant treatment of patients with angioedema in real-world clinical practice. Allergy, 72, 994–998.
Chicago
Zanichelli, A., M. Maurer, W. Aberer, T. Caballero, H. J. Longhurst, L. Bouillet, V. Fabien, et al. 2017. “Long-Term Safety of Icatibant Treatment of Patients with Angioedema in Real-World Clinical Practice.” Allergy 72 (March): 994–98. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....fb01c266c11afac0e4a5e05fdf4a6c39&authtype=sso&custid=ns315887.